Activation of the A3 adenosine receptor affects cell cycle progression and cell growth

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 3, 2000, Pages 225-234

  Brambilla, Roberta ^a   Cattabeni, Flamino ^a   Ceruti, Stefania ^a   Barbieri, Daniela ^b   Franceschi, Claudio ^b   Kim, Yong Chul ^c   Jacobson, Kenneth A ^c   Klotz, Karl Norbert ^d   Lohse, Martin J ^d   Abbracchio, Maria P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine; Adenosine receptor; Cell cycle; Cell growth modulation; CHO transfected cells; HEK293 transfected cells; Human A3

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 CHLORO 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 5,9 DIHYDRO 6 METHOXYCARBONYL 9 METHYL 2 PHENYL 1,2,4 TRIAZOLO[5,1 A][2,7]NAPHTHYRIDINE; 6 CARBOXYMETHYL 5,9 DIHYDRO 9 METHYL 2 PHENYL[1,2,4]TRIAZOLO[5,1 A][2,7]NAPHTHYRIDINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 9 CHLORO 2 (2 FURYL) 5 PHENYL ACETYLAMINO[1,2,4]TRIAZOLO[1,5 C]QUINAZOLINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; DIHYDROPYRIDINE DERIVATIVE; NAPHTHYRIDINE DERIVATIVE; RECEPTOR SUBTYPE; TRIAZOLOQUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ADENYLATE CYCLASE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE; QUINAZOLINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL SURVIVAL; CHO CELL; CONTROLLED STUDY; DRUG ANTAGONISM; GROWTH CURVE; GROWTH REGULATION; HUMAN; HUMAN CELL; NONHUMAN; RECEPTOR DENSITY; ANALYSIS OF VARIANCE; ANIMAL; CELL LINE; CELL MEMBRANE; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HAMSTER; METABOLISM; PHYSIOLOGY;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHO CELLS; CRICETINAE; DIHYDROPYRIDINES; FLOW CYTOMETRY; HUMANS; QUINAZOLINES; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; TRANSFECTION; TRIAZOLES;

EID: 0033624772     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900186     Document Type: Article

References (30)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045
2. L. Studies in human astroglioma cells. Biochem Biophys Res Commun 241:297-304
3. Barbieri D, Abbracchio MP, Salvioli S, Monti D, Cossarizza A, Ceruti S, Brambilla R, Cattabeni F, Jacobson KA, Franceschi C (1998) Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int 32:493-504
4. Ceruti S, Barbieri D, Veronese E, Cattabeni F, Cossarizza A, Giammarioli AM, Malorni W, Franceschi C, Abbracchio MP (1997) Different pathways of apoptosis revealed by 2-chloro-adenosine and deoxy-D-ribose in mammalian astroglial cells. J Neurosci Res 47:372-383
5. Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D (1991) Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 41:549-560
6. De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235: E97-E102
7. Dolbeare F, Gratzner H, Pallavicini M, Gray JW (1983) Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80:5573-5577
8. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
9. 3-selective adenosine agonists. J Med Chem 37:636-646
10. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 115:945-952
11. Jacobson KA, Suzuki F (1996) Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors. Drug Dev Res 39:289-300
12. 3-adenosine receptors: mediation of behavioral depressant effects. FEBS Lett 336:57-60
13. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699
14. 3 adenosine receptor-selective antagonists. Neuropharmacology 36:1157-1165
15. 3 adenosine receptor antagonists. Drug Dev Res 37:131
16. 3 adenosine receptor antagonist. J Med Chem 39:4667-4675
17. Kenakin TP (1996) The classification of seven transmembrane receptors in recombinant expression systems. Physiol Rev 48:413-463
18. 3-adenosine receptors. J Med Chem 37:3614-3621
19. 3 receptor subtype. J Med Chem 39:4142-4148
20. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes. Characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 357:1-9
21. 3 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 360:103-108
22. 3 receptor agonists. Biochem Biophys Res Commun 219:904-910
23. 3 receptors: pharmacological properties, species-differences and receptor functions. Trends Pharmacol Sci 15:298-306
24. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67
25. Manthorpe M, Fagnani R, Skaper SD, Varon S (1986) An automated colorimetric micro assay for neurotrophic factors. Dev Brain Res 25:191-198
26. 1 adenosine receptors of intact rat ventricular myocytes. Circ Res 63:613-620
27. 3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons. Drug Dev Res 40:267-273
28. 3 receptor during prolonged simulated ischemia. Am J Physiol 273:H501-H505
29. +-channel-coupled adenosine receptor in guinea pig atria. Naunyn-Schmiedeberg's Arch Pharmacol 340:684-688
30. 3 antagonists. Biochem Biophys Res Commun 232:317-322